17-28 Panel Cups | Collection

17 to 28 Panel Drug Test Cups

Drug test cups from 17-panel through the 28-Panel Ultra Cup available from $2.09 per cup, covering the full emerging-substance tier where Gabapentin, Xylazine, Kratom, Ketamine, Tianeptine (ZAZA), Delta-8 THC, LSD, Psilocybin, and 6-Monoacetylmorphine first appear as dedicated analyte strips alongside the standard baseline. Every cup in this range is Forensic Use Only and features a built-in temperature strip, a no-drip click-top lid, and 99% accuracy in a 5-minute result window. The 28-Panel Ultra Cup (SM-CDOA-52845AD3) at $4.99 is the first drug test cup on the market to include all 28 analytes in a single sealed collection device. Searching for a 20 panel drug test cup near me or a 28 panel drug test cup near me? 12 Panel Now ships same-day wholesale before 3:00 PM EST anywhere in the US with free shipping on qualifying bulk orders. As the manufacturer of the Serenity brand drug testing product line, 12 Panel Now produces all 17 through 28 panel cups to the same quality and antibody standards applied across the full product range.

What Does a 17 Panel Drug Test Cup Test For?

A 17 panel drug test cup tests for seventeen substances and represents the first tier in the 12 Panel Now lineup where Gabapentin (GAB/1000 ng/mL) and Kratom (KRA/500 ng/mL) both appear as dedicated strips alongside the full opioid, stimulant, sedative, and alcohol baseline, making it the minimum cup format for programs with documented gabapentin or kratom co-use in their supervised populations. The 17 Panel Drug Test Cup (SM-CDOA-6175FUO) screens for: Amphetamines (AMP/1000), Barbiturates (BAR/300), Buprenorphine (BUP/10), Benzodiazepines (BZO/300), Cocaine (COC/300), Ethyl Glucuronide (ETG/300), Fentanyl (FEN/20), Gabapentin (GAB/1000), Kratom (KRA/500), MDMA (MDMA/500), Methamphetamine (MET/1000), Methadone (MTD/300), Opiates/Morphine (OPI/300), Oxycodone (OXY/100), PCP (PCP/25), TCA (TCA/1000), and THC (THC/50), from $2.29 per cup. The addition of Gabapentin over the 16-panel range addresses the documented polysubstance risk pattern identified by the CDC overdose prevention program, which confirms gabapentin’s role in potentiating opioid-related overdose when co-consumed. The Kratom strip at 500 ng/mL addresses the growing use of kratom as a self-treatment for opioid withdrawal and as a substance of misuse in treatment-seeking populations. As the manufacturer of the Serenity brand drug testing product line, 12 Panel Now produces all 17 through 28 panel cups to the same antibody quality standards applied across the full lineup. For dip card equivalents at the 17-panel count, see the 17 Panel Dip Card collection.

What Is the Difference Between the 17 Panel Cup and the 16 Panel Cup?

The 16-panel FUO cup (SM-CDOA-3165FUO) covers ETG, FEN, TCA, and TRA as its specialty additions to the standard baseline. The 17-panel cup (SM-CDOA-6175FUO) adds Gabapentin (GAB) and Kratom (KRA) as the two new analytes, simultaneously covering the gabapentin polysubstance risk and kratom use monitoring that neither the 16-panel nor any lower format addresses. The 17-panel is the transition point from prescription-focused specialty coverage into the emerging-substance tier, and it is the minimum cup format at 12 Panel Now that covers GAB+KRA+ETG+FEN in a single device. For programs whose monitoring data shows both kratom and gabapentin use alongside opioids, the 17-panel cup eliminates the need to pair a lower-panel cup with supplemental dip cards for those two analytes. All results are presumptive and must be confirmed by GC-MS or LC-MS/MS before any consequential action is taken.

What Does an 18 Panel Drug Test Cup Test For?

An 18 panel drug test cup tests for eighteen substances and is the minimum cup format at 12 Panel Now where Ketamine (KET/1000 ng/mL) appears as a dedicated strip, making it the appropriate selection for harm reduction programs, emergency departments, and forensic settings where ketamine use or diversion from medical and veterinary sources is a documented concern. At 12 Panel Now, the 18-panel cup is available in five configurations addressing different specialty analyte priorities. The base 18-panel FUO (SM-CDOA-9185FUO at $2.09) adds Ketamine alongside Tramadol, TCA, ETG, and FEN to the standard baseline. The 18-panel with KRA+XYL (SM-CDOA-5185-FUO at $2.39) replaces TCA with Xylazine (XYL/1000 ng/mL) and Kratom for programs where the fentanyl-xylazine polysubstance pattern in the illicit opioid supply is a primary monitoring concern. The 18-panel with GAB+ADLTX (SM-CDOA-2185AD3-FUO at $2.39) includes Gabapentin alongside KET, TRA, ETG, FEN, and three ADLTX specimen validity strips. The 18-panel with KRA+ADLTX (SM-CDOA-9185AD3FUO at $2.09) combines Kratom coverage with specimen validity checking in the same cup. The 18-panel economy 90mL (SM-CDOA-3186-FUO-90 at $2.19) provides the standard 18-panel substance coverage in a cost-reduced 90mL format for high-volume programs where per-test cost is the primary operational constraint. The NIH documentation on ketamine pharmacology and misuse patterns confirms that ketamine’s dissociative effects, Schedule III DEA classification, and diversion from medical and veterinary settings make dedicated KET strip coverage relevant for programs monitoring patient populations with documented ketamine access. For dip card equivalents at the 18-panel count, see the 18 Panel Dip Card collection.

What Is Xylazine on a Drug Test and Which 18 Panel Cup Tests for It?

What is xylazine on a drug test? Xylazine (XYL/1000 ng/mL) detects the veterinary sedative increasingly used as a fentanyl supply adulterant, making the xylazine drug test cup one of the most urgently demanded emerging analyte devices in the 2024 to 2026 drug supply, as it produces severe wound necrosis, respiratory depression, and reversal-resistant overdose that naloxone cannot reverse, and it first appears as a dedicated XYL strip on the 18-panel cup with KRA+XYL (SM-CDOA-5185-FUO) and continues through the 20, 22, and 28 panel cups. Xylazine is an alpha-2 adrenergic agonist approved only for veterinary use in the United States. It is not classified as a controlled substance at the federal level, but the Department of Health and Human Services declared it an emerging threat to the nation’s drug supply in 2023, and the HHS xylazine emergency designation confirmed its co-detection alongside fentanyl in the majority of illicit opioid supply samples in multiple geographic markets. The 18-panel cup with KRA+XYL (SM-CDOA-5185-FUO, from $2.39) is the minimum format at 12 Panel Now where XYL appears as a standard built-in strip. The 20-panel cup (SM-CDOA-3205AD3-FUO) and the 22-panel cup (SM-CDOA-9225AD3FUO) also include XYL alongside additional specialty analytes. All XYL presumptive positive results must be confirmed by GC-MS or LC-MS/MS before any clinical interpretation.

What Does the 20 Panel Drug Test Cup Test For?

The 20 panel drug test cup (SM-CDOA-3205AD3-FUO) from $2.59 tests for twenty substances simultaneously and is the most comprehensive single-configuration standard cup at 12 Panel Now before the 22-panel tier, covering the complete standard baseline plus Ethyl Glucuronide (ETG/300), Fentanyl (FEN/20), Gabapentin (GAB/1000), K2/Synthetic Cannabinoids (K2/50), Ketamine (KET/1000), Kratom (KRA/500), Tramadol (TRA/100), Xylazine (XYL/1000), and 6-MAM (6-Monoacetylmorphine/10 ng/mL) alongside three ADLTX specimen validity strips. What does a 20 panel drug test test for? The full 20-panel substance list covers AMP/1000, BAR/300, BUP/10, BZO/300, COC/300, ETG/300, FEN/20, GAB/1000, K2/50, KET/1000, KRA/500, MDMA/500, MET/1000, MTD/300, OPI/300, OXY/100, PCP/25, TRA/100, XYL/1000, and THC/50, plus Specific Gravity, pH, and Creatinine for specimen integrity verification. The 20-panel cup is used by correctional facilities, law enforcement agencies, probation programs in markets with documented emerging-substance patterns, and residential treatment programs requiring comprehensive single-device screening for populations presenting with polysubstance use. The SAMHSA 2024 NSDUH report documents polysubstance use across multiple emerging analyte classes as a consistently growing pattern in treatment-seeking and justice-involved populations.

What Is Gabapentin on the 20 Panel Drug Test Cup?

Gabapentin (GAB/1000 ng/mL) on the gabapentin drug test cup, specifically the 20 panel drug test cup (SM-CDOA-3205AD3-FUO), detects gabapentin at concentrations consistent with above-therapeutic use. Multiple states have scheduled gabapentin as a controlled substance because of its documented role in potentiating opioid effects and its increasing appearance in overdose toxicology reports alongside fentanyl. The CDC overdose prevention polysubstance use documentation confirms gabapentin as a co-intoxicant in opioid overdose cases. For programs that already use the 13-panel FUO cup with GAB and need to add Xylazine, K2, and Kratom coverage simultaneously, the 20-panel cup is the appropriate upgrade path that combines all four emerging analytes in a single device. As with all presumptive immunoassay results, a positive GAB result requires GC-MS or LC-MS/MS confirmation before any clinical or consequential action.

What Is Tianeptine (ZAZA) on a Drug Test?

What is tianeptine ZAZA drug test positive result? Tianeptine (TIA/ZAZA) detected at 500 ng/mL on the 22 Panel Drug Test Cup (SM-CDOA-9225AD3FUO) indicates the presence of tianeptine, an atypical antidepressant and opioid receptor agonist sold in convenience stores and gas stations under brand names including “Tianaa,” “ZaZa,” and “TD Red,” which produces opioid-like euphoria, physical dependence, and severe withdrawal at high doses and has been scheduled as a Schedule I controlled substance in Alabama, Georgia, Indiana, Michigan, Mississippi, Virginia, and other states. What is ZAZA on a drug test? ZAZA refers to the brand name “ZaZa” or “Zaza Red,” which contains tianeptine as its active compound. Tianeptine is not FDA-approved for any medical use in the United States but is legally sold as a dietary supplement in states where it has not been scheduled. At doses used recreationally, it produces full opioid-like effects by binding mu-opioid receptors directly. Its rapid elimination requires frequent redosing, which drives a severe physical dependency pattern. The DEA has listed tianeptine as a “Drug of Concern” and multiple state legislatures have passed or are pursuing Schedule I classification. The 22-panel cup is the minimum configuration at 12 Panel Now that includes a dedicated TIA/ZAZA strip, making it the appropriate format for programs in states where tianeptine is scheduled or prevalent. As with all results from this cup, TIA presumptive positives require GC-MS or LC-MS/MS confirmation before any clinical or legal action.

What Does the 22 Panel Drug Test Cup Test For?

The 22 Panel Drug Test Cup (SM-CDOA-9225AD3FUO) from $2.89 screens for: AMP/1000, BAR/300, BUP/10, BZO/300, COC/300, ETG/300, FEN/20, KET/1000, K2/50, KRA/500, MDMA/500, MET/1000, MTD/300, OPI/300, OXY/100, PCP/25, TCA/1000, TRA/100, THC/50, Delta-8 THC/25, XYL/1000, and ZAZA/TIA/500, plus Specific Gravity, pH, and Creatinine validity strips. What does a 22 panel drug test test for in terms of emerging synthetic substances? The 22-panel is the first cup in this range to include Delta-8 THC as a separate dedicated strip alongside the standard THC/50 strip, addressing the documented detection gap created by the widespread availability of Delta-8 THC products in legal markets. The ZAZA/TIA (Tianeptine) strip, the XYL (Xylazine) strip, and the K2 (Synthetic Cannabinoids) strip together cover the three most clinically significant non-traditional substances absent from all standard 5 through 16 panel configurations. Visit the 22 Panel Drug Test Cup product page for the complete substance list and cutoff reference.

What Is the 28 Panel Ultra Drug Test Cup?

The 28 Panel Ultra Drug Test Cup (SM-CDOA-52845AD3) at $4.99 is the first drug test cup on the market to detect 28 substances in a single sealed collection, adding LSD (LSD/50 ng/mL), 6-Monoacetylmorphine (6-MAM/10 ng/mL), Psilocybin/Mushrooms (PY/500 ng/mL), and Flakka/alpha-PVP (a-PVP/500 ng/mL) to the complete 22-panel substance baseline, and features a square cup design engineered for direct photocopying of results into chain-of-custody documentation without a scanner or camera. What does a 28 panel drug test test for? The Ultra 28 Panel Cup covers: AMP/1000, BAR/300, BUP/10, BZO/300, COC/300, ETG/300, FEN/20, KET/1000, K2/50, KRA/500, LSD/50, 6-MAM/10, MDMA/500, MET/1000, MPD/1000, MTD/300, OPI/300, OXY/100, PCP/25, PY/500, TCA/1000, TRA/100, a-PVP/500, XYL/1000, TIA/500, THC/25, THC/50, and Flakka (a-PVP), plus Specific Gravity, pH, and Creatinine validity strips for specimen integrity. This is the most comprehensive point-of-care urine drug test cup available in the US market and is designed for law enforcement booking suites, forensic toxicology screening intake workflows, federal prison systems, and any setting requiring immediate multi-substance characterization of an unknown intake where the substance profile is not predictable from the presenting population. As the manufacturer of the Serenity brand drug testing product line, 12 Panel Now is the US manufacturer who first brought the 28-panel cup to market.

What Is 6-MAM on a Drug Test and Why Does the 28 Panel Cup Include It?

What is 6-MAM on a drug test? 6-MAM on the 28 Panel Drug Test Cup stands for 6-Monoacetylmorphine, the only metabolite unique to heroin that definitively distinguishes heroin use from prescription opioid use or poppy seed consumption, because 6-MAM at 10 ng/mL is produced only when diacetylmorphine (heroin) is metabolized and cannot be generated by morphine, codeine, hydromorphone, oxycodone, or any other opioid other than heroin itself. The standard OPI strip at 300 ng/mL on all lower panels tests for morphine, the primary metabolite shared by heroin, codeine, and prescription morphine. A positive OPI result cannot distinguish between heroin use, prescription morphine or codeine use, or false positivity from poppy seed ingestion. The 6-MAM strip at 10 ng/mL on the 28-panel Ultra Cup is the only point-of-care test that proves heroin specifically, making it the required analyte for law enforcement intake screening, forensic toxicology investigations, and any context where the legal or clinical distinction between heroin and prescription opiate use is consequential. The SAMHSA Mandatory Guidelines document 6-MAM as the heroin-specific biomarker whose detection provides definitive confirmation of heroin use. All 6-MAM presumptive positive results must be confirmed by GC-MS or LC-MS/MS testing before any legal, clinical, or consequential determination is made.

Does Drug Test Detect Psilocybin (Mushrooms)?

Does drug test detect psilocybin? Yes, the 28 Panel Ultra Cup includes a dedicated PY (Psilocybin/500 ng/mL) strip that detects psilocybin and its primary urinary metabolite psilocin at concentrations consistent with recent psychedelic mushroom consumption. Psilocybin is a Schedule I controlled substance under the DEA Controlled Substances Act and is not detected on any standard 5 through 22 panel cup configuration. The 28 Panel Ultra Cup at 12 Panel Now is the only cup format that includes both PY (Psilocybin) and LSD (LSD/50 ng/mL) as dedicated strips in a single device, covering both classical hallucinogens alongside the full synthetic drug, opioid, stimulant, sedative, and emerging-substance baseline. For programs at correctional facilities, federal prisons, and law enforcement booking settings where the complete unknown-substance intake profile is the primary testing goal, the 28-panel Ultra Cup provides the broadest single-device point-of-care analyte coverage available in the US market.

Who Uses 17 Through 28 Panel Drug Test Cups?

The 17 through 28 panel drug test cup range is used by correctional facilities and law enforcement booking suites requiring comprehensive emerging-substance coverage, forensic toxicology intake programs needing single-device characterization of unknown substance profiles, harm reduction programs monitoring for xylazine and fentanyl polysubstance patterns in the illicit opioid supply, residential treatment programs managing populations with documented synthetic cannabinoid or kratom use alongside standard opioid misuse, probation programs in jurisdictions where tianeptine is scheduled and monitored, pain management clinics requiring gabapentin and tramadol compliance monitoring, and emergency departments conducting rapid toxicology screening in markets where the 2024 to 2026 fentanyl-xylazine supply pattern is documented. Federal and state correctional facilities use the 20 and 22 panel cups because the intake population presents with unpredictable polysubstance profiles that include synthetic cannabinoids (K2), kratom, xylazine, and tianeptine at frequencies that make lower-panel formats insufficient. Probation programs and drug courts in states where tianeptine is scheduled use the 22-panel cup for its ZAZA/TIA strip. Residential treatment programs and sober living homes in markets with documented K2, kratom, and gabapentin co-use use the 18 or 20 panel configurations as their standard monitoring cup. Law enforcement agencies requiring heroin-specific detection distinct from prescription opiates use the 28 Panel Ultra Cup for its 6-MAM strip. The Quest Diagnostics 2025 Drug Testing Index documents the consistent expansion of positive test results for synthetic cannabinoids and emerging opioid-adjacent substances across multiple workforce and forensic testing populations.

How Does the 17-28 Panel Range Relate to the 13-16 Panel Cups?

The 13 through 16 panel cup range covers fentanyl, EDDP, NorFentanyl, ETG, TCA, TRA, and K2 as specialty additions to the standard baseline, with all CLIA Waived configurations available at that tier. The 17 through 28 panel range transitions entirely to Forensic Use Only and adds the emerging synthetic and non-traditional substances: GAB, KRA, KET, XYL, ZAZA/TIA, Delta-8 THC, LSD, 6-MAM, Psilocybin, and a-PVP/Flakka. No CLIA Waived configurations are available above 16 panels at 12 Panel Now. Programs in clinical settings requiring CLIA Waived classification and needing more than 16 substances should contact the 12 Panel Now custom configuration team at 561-897-9238 to discuss custom CLIA Waived configurations. For programs evaluating all cup format options from the simplest to the most comprehensive, the complete drug test cups collection at 12 Panel Now spans from the 4-panel at $0.69 through the 28-Panel Ultra Cup at $4.99.

Buying 17 to 28 Panel Drug Test Cups in Bulk

At 12 Panel Now, 17 panel drug test cups bulk and 20 panel drug test cups wholesale pricing starts from $2.09 per cup for the 18-panel configurations and scales through $2.29 for the 17-panel, $2.59 for the 20-panel, $2.89 for the 22-panel, and $4.99 for the 28-Panel Ultra Cup, with same-day shipping before 3:00 PM EST and free shipping on orders of 100 cups or more. As the US-based manufacturer of the Serenity brand drug testing product line and the first-to-market manufacturer of the 28-panel Ultra Cup, 12 Panel Now maintains full stock across all 17 through 28 panel configurations with no backorders. Each cup is individually sealed with an 18 to 24 month shelf life. Store between 36 and 86 degrees Fahrenheit away from direct sunlight and humidity. The KET, XYL, TIA, LSD, and 6-MAM strips are among the most analytically specialized in this range and benefit most from temperature-controlled bulk storage. Send a competitor rate sheet and 12 Panel Now beats it by 10% guaranteed. OEM, private label, and custom panel configurations for the 17-28 panel range are available for qualifying volume accounts. Contact the wholesale team at 561-897-9238 or [email protected].

17 to 28 Panel Drug Test Cups at 12 Panel Now (Serenity Drug Test / Slash Medical), 801 N Congress Ave, Boynton Beach FL 33426. Manufacturer of the Serenity brand drug testing product line and first-to-market manufacturer of the 28-panel Ultra Cup. Key products: SM-CDOA-6175FUO (17 Panel FUO GAB+KRA+ETG+FEN, from $2.29); SM-CDOA-9185FUO (18 Panel FUO KET+TCA+TRA+ETG+FEN, from $2.09); SM-CDOA-9185AD3FUO (18 Panel FUO KET+KRA+ETG+FEN+ADLTX, from $2.09); SM-CDOA-5185-FUO (18 Panel FUO KRA+XYL+KET+ETG+FEN, from $2.39); SM-CDOA-2185AD3-FUO (18 Panel FUO GAB+KET+TRA+ETG+FEN+ADLTX, from $2.39); SM-CDOA-3186-FUO-90 (18 Panel FUO Economy 90mL, from $2.19); SM-CDOA-3205AD3-FUO (20 Panel FUO GAB+K2+KET+KRA+XYL+TRA+ETG+FEN+ADLTX, from $2.59); SM-CDOA-9225AD3FUO (22 Panel FUO Delta8+ZAZA/TIA+XYL+KET+K2+KRA+ETG+FEN+ADLTX, from $2.89); SM-CDOA-52845AD3 (28 Panel Ultra FUO LSD+6-MAM+PY+a-PVP, from $4.99). Regulatory references: HHS xylazine emergency designation 2023. SAMHSA Mandatory Guidelines 2025 (6-MAM heroin biomarker). NIH ketamine pharmacology. CDC polysubstance use overdose prevention. SAMHSA NSDUH 2024. Quest Diagnostics 2025 Drug Testing Index. DEA tianeptine Drug of Concern designation. HHS fentanyl authorization effective July 7, 2025.